Posters and Presentations

  1. Hasadsri L, Loken P, Gavrilov DK, Matern D, Raymond K, Rinaldo P, Tortorelli S, Oglesbee D. Detection of 4-hydroxy-2-oxoglutarate aldolase metabolites in urine for the diagnosis and monitoring of primary hyperoxaluria type III. Poster presented at: American Society of Human Genetics; 2013; Boston, Mass.
  2. Teigen CM, Hasadsri L, Hesemann JL, Schultz EA, Edward KK, Bryant SC, Highsmith WE, Oglesbee D. The Mitochondrial Disease Biobank at Mayo Clinic: Three mighty years and counting. Poster presented at: Upper Midwest Clinical Genetics Conference; 2013; Minneapolis, Minn.
  3. Hasadsri L, Gavrilov DK, Matern D, Oglesbee D, Raymond K, Tortorelli S, McHugh D, Marquardt G, Rinaldo P. Clinical utility of post-analytical tools for the diagnosis of glutaric acidemia type II by urine acylglycine analysis. Poster presented at: 12th International Congress of Inborn Errors of Metabolism; 2013; Barcelona, Spain.
  4. Hasadsri L, Tortorelli S, Oglesbee D, Gavrilov DK, Matern D, Raymond K, Rinaldo P, Gavrilova RH. Woodhouse-Sakati syndrome with 3-methylglutaconic aciduria and coenzyme Q10 deficiency. Poster presented at: 12th International Congress of Inborn Errors of Metabolism; 2013; Barcelona, Spain.
  5. Hasadsri L. From biochemistry to muscle biopsies as part of the understanding and navigating through your test results (patient-family workshop). Poster and panel presented at: United Mitochondrial Disease Foundation: Mitochondrial Medicine Conference; 2013; Newport Beach, Calif.
  6. Pureza V, Hasadsri L, Highsmith WE, Oglesbee D. Clinical features and progression of cardiomyopathy in patients with Friedreich's ataxia. Poster and panel presented at: United Mitochondrial Disease Foundation: Mitochondrial Medicine Conference; 2013; Newport Beach, Calif.
  7. Hasadsri L, Eisenberg LR, Anderson C, Hesemann JL, Schultz EA, Edward KK, Bryant SC, Highsmith WE, Oglesbee D. The Mitochondrial Disease Biobank at Mayo Clinic: Three mighty years and counting. Poster presented at: United Mitochondrial Disease Foundation: Mitochondrial Medicine Conference; 2013; Newport Beach, Calif.
  8. Hasadsri L, Gavrilov DK, Matern D, Oglesbee D, Raymond K, Tortorelli S, McHugh D, Marquardt G, Rinaldo P. Clinical utility of post-analytical tools for the diagnosis of glutaric acidemia Type II by urine acylglycine analysis. Poster presented at: American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting; 2013; Phoenix, Ariz.
  9. Eisenberg LR, Anderson C, Hesemann JL, Highsmith WE, Oglesbee D. The tangled Web: The rare disease biobank and the internet age. Lecture at: American Society for Bioethics and Humanities Annual Meeting; 2012; Washington, D.C.
  10. Eisenberg LR, Anderson JR. A form of comic relief: HIPAA in graphic detail. Lecture at: Comics & Medicine: Navigating the Margins; 2012; Toronto, Canada.
  11. Eisenberg LR, VanDenBoom AR, Highsmith WE, Oglesbee D. It's all relative: Does HIPAA permit researchers to identify prospective biobank participants based on health information provided by family members? Poster presented at: American Society for Bioethics and Humanities Annual Meeting; 2011; Minneapolis, Minn.
    View the presentation (PDF).
  12. Eisenberg LR, VanDenBoom AR, Highsmith WE, Oglesbee D. Enrolling children with mitochondrial disease in a research biobank: The challenge of meaningful assent. Poster presented at: American Society of Human Genetics Annual Meeting; 2010; Washington, D.C.
    View the presentation (PDF).